[ad_1]
Solar Pharma Superior Analysis Firm Ltd., integrated within the 12 months 2006, is a Mid Cap firm (having a market cap of Rs 8462.08 Crore) working in Prescription drugs sector.
Solar Pharma Superior Analysis Firm Ltd. key Merchandise/Income Segments embody Sale of providers for the 12 months ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the corporate reported a Standalone Complete Revenue of Rs 33.85 Crore, up 48.53 % from final quarter Complete Revenue of Rs 22.79 Crore and up 65.44 % from final 12 months similar quarter Complete Revenue of Rs 20.46 Crore. Firm reported web revenue after tax of Rs -55.14 Crore in newest quarter.
Funding Rationale
The inventory is on the verge of a breakout from a bullish Flag sample suggesting bullishness increase. A sustained commerce above Rs 334 will take it increased to ranges of Rs 345. RSI can be suggesting the identical.
(Disclaimer: Suggestions given on this part or any reviews hooked up herein are authored by an exterior social gathering. Views expressed are that of the respective authors/entities. These don’t characterize the views of Financial Occasions (ET). ET doesn’t assure, vouch for, endorse any of its contents and hereby disclaims all warranties, categorical or implied, regarding the identical. Please seek the advice of your monetary adviser and search unbiased recommendation.
[ad_2]
Source link
